Breaking News

Exagen Inc (XGN)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

1.410 +0.040 +2.92%

- Real-time Cboe. Currency in USD ( Disclaimer )

Type: Equity

Market: United States

Volume: 13,586
Bid/Ask: 0.000 / 0.000
Day's Range: 1.358 - 1.410

Exagen Inc Company Profile

Get an in-depth profile of Exagen Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryHealthcare Providers & Services

SectorHealthcare

Employees

202

Equity Type

ORD

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient’s blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

Contact Information

Address 1261 Liberty Way Suite C
Vista, 92081
United States

Phone 760 560 1501

Fax -

Web www.exagen.com

Top Executives

Name	Age	Since	Title
Mark D. Pegram	-	-	Member of Breast Cancer Advisory Board
Raymond R. Tubbs	-	-	Member of Breast Cancer Advisory Board
Lyndsay N. Harris	-	-	Member of Breast Cancer Advisory Board
Michael F. Press	-	-	Member of Breast Cancer Advisory Board
Kenneth J. Bloom	66	-	Member of Breast Cancer Advisory Board
William J. Sandborn	61	-	Member of Science Advisory Board
Tina S. Nova	70	2019	Executive Chairman of the Board of Directors
Brian Peter Birk	65	2008	Independent Director
Stephen B. Hanauer	-	-	Member of Science Advisory Board
Thomas Williams	-	-	Member of Breast Cancer Advisory Board
David T. Rubin	-	-	Member of Science Advisory Board
Anca Dinu Askanase	-	2019	Member of Scientific Advisory Board
Ebetuel Pallares	51	2012	Independent Director
Bruce C. Robertson	61	2019	Independent Director
Harris Perlman	-	2022	Member of Rheumatoid Arthritis Scientific Advisory Board
Paul Kim	57	2023	Director
Kevin Deane	-	2022	Member of Rheumatoid Arthritis Scientific Advisory Board
John Aballi	39	2022	CEO, President & Director
Stanley B. Cohen	-	2022	Member of Rheumatoid Arthritis Scientific Advisory Board
Andrew L. Concoff	-	2019	Chief Innovation Officer & Member of Rheumatoid Arthritis Scientific Advisory Board
Vasileios Kyttaris	-	2019	Member of Scientific Advisory Board
Joel M. Kremer	-	-	Member of Scientific Advisory Board
Paul J. DeMarco	-	2022	Member of Rheumatoid Arthritis Scientific Advisory Board
Frank Stokes	53	2021	Independent Director
Arthur Weinstein	80	2013	Chairman of Scientific Advisory Board
Ana Hooker	57	2021	Independent Director
Eric M. Ruderman	-	2022	Member of Rheumatoid Arthritis Scientific Advisory Board
Marina Sirota	-	2022	Member of Rheumatoid Arthritis Scientific Advisory Board
Wendy S. Johnson	72	2020	Independent Director
Maureen A. McMahon	-	2019	Member of Scientific Advisory Board

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

XGN Comments

Write your thoughts about Exagen Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Ali Çınar Mar 20, 2024 10:24AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

garbage

0 0

Report

Dejan Kolmanic Dec 17, 2020 1:29PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

up it goes, $17

0 0

Report

Dejan Kolmanic Dec 17, 2020 1:28PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

up it goes, $17

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="219662336">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="219662336" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="219662336" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="219662336">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	38,079.6	-381.3	-0.99%
US 500	5,049.8	-21.8	-0.43%
Dow Jones	38,077.78	-383.14	-1.00%
S&P 500	5,050.00	-21.63	-0.43%
Nasdaq	15,610.09	-102.66	-0.65%
S&P 500 VIX	16.11	+0.14	+0.88%
Dollar Index	105.410	-0.290	-0.27%

Crude Oil WTI	83.67	+0.86	+1.04%
Brent Oil	89.10	+1.08	+1.23%
Natural Gas	1.977	-0.002	-0.10%
Gold	2,346.20	+7.80	+0.33%
Silver	27.420	+0.074	+0.27%
Copper	4.5410	+0.0835	+1.87%
US Soybeans	1,162.25	-3.75	-0.32%

U.S. 10Y	4.704	+0.052	+1.12%
U.S. 30Y	4.820	+0.036	+0.75%
U.S. 5Y	4.717	+0.058	+1.25%
U.S. 3M	5.419	+0.014	+0.26%
US 10Y T-Note	107.38	-0.36	-0.33%
Euro Bund	129.72	-0.38	-0.29%
10-2 Yield Spread	-28.51	+4.78	+-14.36%

Apple	169.89	+0.87	+0.51%
Alphabet A	155.94	-3.19	-2.01%
Tesla	168.18	+6.05	+3.73%
Amazon.com	173.29	-3.30	-1.87%
Netflix	564.93	+9.81	+1.77%
Meta Platforms	439.64	-53.86	-10.91%
Bank of America	37.95	-0.37	-0.95%

Recent Quotes

	Name	Price	Chg.	Chg. %
	XGN	1.410	+0.040	+2.92%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	168.00	+3.62%	96.89M
META	439.19	-11.00%	73.09M
AMZN	173.25	-1.89%	34.82M
NVDA	829.59	+4.12%	34.63M
AAPL	169.85	+0.49%	32.43M
MSFT	397.14	-2.91%	26.68M
BRKa	612,300	-0.18%	12.27K

Name	Last	Chg. %	Vol.
NEM	43.84	+13.58%	28.50M
TYL	455.44	+8.70%	341.37K
TER	109.25	+8.49%	5.61M
CARR	59.38	+8.42%	6.86M
CMG	3,116.19	+6.47%	515.36K
URI	693.75	+5.89%	711.09K
AZN	75.23	+5.66%	11.83M

Name	Last	Chg. %	Vol.
META	439.05	-11.03%	73.11M
TXT	85.47	-9.08%	3.71M
IBM	168.02	-8.73%	13.45M
BMY	44.72	-8.47%	34.80M
LUV	26.91	-8.17%	28.64M
CAT	340.11	-6.44%	4.64M
CMCSA	38.01	-5.48%	25.76M